Amarantus Bioscience Holdings Inc (AMBS)

[Goldstrike]

Well, let’s see, you have a top tier OTC company, fully transparent and Edgar Compliant, racing on the fast track toward getting their first-of-a-kind NuroPro Parkinson's Diagnostic Blood Test on the market. Couple that with a rousing endorsement and buy in by Dr. Joseph Rubinfield of Amgen, who along with his scientific expertise will assist management in positioning the Company's development programs for partnering. Then there’s full, uncontested rights to the MANF protein and subsequent research and development of MANF-based products, and well, simply put, this is that “needle in a haystack” opportunity that comes along only very rarely for investors!